DOJ expands health care fraud probes with AI tools — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- DOJ officials announced an expansion of health care fraud investigations into corporate wrongdoing at the STAT Summit in Boston, with Deputy Assistant Attorney General Jacob Foster leading the announcement Thursday.
- The health care fraud section at DOJ will now serve as a one-stop shop for voluntary self-disclosures, consolidating what was previously a separate process at the Department of Health and Human Services.
- Companies that report potential criminal misconduct can receive benefits including limited caps on financial damages from both DOJ and HHS simultaneously.
- Foster's fraud enforcement unit will deploy data analytics and AI algorithms to detect providers billing for unneeded services, companies fabricating patient records, and health tech firms adding redundant diagnoses.
- An Oct. 1 memo from Assistant Attorney General Colin M. McDonald directs prosecutors to prioritize schemes involving controlled substances and violations of the federal Food, Drug, and Cosmetic Act.
- New whistleblower programs will be designed to "appropriately incentivize" reporting of fraud, and prosecutors will weigh factors like scheme duration over three years and whether executives knew of or concealed fraud.
Why it matters: Health care companies gain a single DOJ doorway for self-disclosure but face AI-driven detection of billing fraud, fabricated records, and redundant diagnoses — raising the cost of concealment. Prosecutors will now weigh executive knowledge and multi-state schemes more heavily, putting corporate leadership under direct scrutiny rather than just institutional fines.
Ask SkimNews
